Proliferative markers as prognostic and predictive tools in early breast cancer : where are we now?COLOZZA, M; AZAMBUJA, E; CARDOSO, F et al.Annals of oncology. 2005, Vol 16, Num 11, pp 1723-1739, issn 0923-7534, 17 p.Article

Molecular markers of head and neck squamous cell carcinoma : Promising signs in need of prospective evaluationLOTHAIRE, Phillipe; DE AZAMBUJA, Evandro; DEQUANTER, Didier et al.Head & neck. 2006, Vol 28, Num 3, pp 256-269, issn 1043-3074, 14 p.Article

MCM-2 and MCM-5 Expression in Gastric Adenocarcinoma: Clinical Significance and Comparison with Ki-67 Proliferative MarkerGIAGINIS, Constantinos; GIAGINI, Athina; TSOUROUFLIS, Gerasimos et al.Digestive diseases and sciences. 2011, Vol 56, Num 3, pp 777-785, issn 0163-2116, 9 p.Article

A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. CommentaryYAMADA, Shozo; OHYAMA, Kenichi; POST, Kalmon D et al.Neurosurgery. 2007, Vol 61, Num 3, pp 580-585, issn 0148-396X, 6 p.Article

Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma : a clinical and histopathological analysis of 113 patientsMYOUNG, H; KIM, M.-J; LEE, J.-H et al.International journal of oral and maxillofacial surgery. 2006, Vol 35, Num 11, pp 1005-1010, issn 0901-5027, 6 p.Article

Biomarkers of Pituitary NeoplasmsSAV, Aydin; ROTONDO, Fabio; SYRO, Luis V et al.Anticancer research. 2012, Vol 32, Num 11, pp 4639-4654, issn 0250-7005, 16 p.Article